Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Burke

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
Respiratory Medicine and Research|December 30, 2025
Real-world outcomes of patients treated with ≥17 cycles of pembrolizumab monotherapy as first-line therapy and for previously treated advanced NSCLC: multicenter observational study in FranceMaurice Pérol, Clarisse Audigier-Valette, Hervé Léna, et al.
Ultrasound in Medicine & Biology|August 10, 2010
Focused maternal ultrasound by midwives in rural ZambiaHeidi Harbison Kimberly, Alice Murray, Maria Mennicke, et al.
Cancer|February 26, 2009
Phase 2 trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcomaLois M Ramondetta, Alaina J Johnson, Charlotte C Sun, et al.
American Journal of Public Health|July 18, 2014
Role of health insurance on the survival of infants with congenital heart defectsJames E Kucik, Cynthia H Cassell, Clinton J Alverson, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|June 11, 2021
Resource use decrease after implementation of care bundles for treatment of postpartum hemorrhageMaría Fernanda Escobar, Paola Valencia, Lina María Jaimes, et al.
JTO Clinical and Research Reports|September 6, 2022
First-Line Pembrolizumab Monotherapy for Advanced NSCLC With Programmed Death-Ligand 1 Expression Greater Than or Equal to 50%: Real-World Study Including Older Patients in JapanYasushi Goto, Atsuhisa Tamura, Hirotaka Matsumoto, et al.
PLOS Global Public Health|November 1, 2024
"How I wish we could manage such things": A qualitative assessment of barriers to postpartum hemorrhage management and referral in KenyaNora Miller, Junita Henry, Kennedy Opondo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 2, 2009
Human biospecimen research: experimental protocol and quality control toolsFotini Betsou, Rebecca Barnes, Thomas Burke, et al.
Cancers|June 24, 2022
Real-World Treatments and Clinical Outcomes in Advanced NSCLC without Actionable Mutations after Introduction of Immunotherapy in JapanHiroshi Nokihara, Takashi Kijima, Toshihide Yokoyama, et al.
The Journal of Infectious Diseases|January 21, 2016
Transcriptomic Analysis of the Host Response and Innate Resilience to Enterotoxigenic Escherichia coli Infection in HumansWilliam E Yang, Sunil Suchindran, Bradly P Nicholson, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
Respiratory Medicine and Research|December 30, 2025
Real-world outcomes of patients treated with ≥17 cycles of pembrolizumab monotherapy as first-line therapy and for previously treated advanced NSCLC: multicenter observational study in FranceMaurice Pérol, Clarisse Audigier-Valette, Hervé Léna, et al.
Ultrasound in Medicine & Biology|August 10, 2010
Focused maternal ultrasound by midwives in rural ZambiaHeidi Harbison Kimberly, Alice Murray, Maria Mennicke, et al.
Cancer|February 26, 2009
Phase 2 trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcomaLois M Ramondetta, Alaina J Johnson, Charlotte C Sun, et al.
American Journal of Public Health|July 18, 2014
Role of health insurance on the survival of infants with congenital heart defectsJames E Kucik, Cynthia H Cassell, Clinton J Alverson, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|June 11, 2021
Resource use decrease after implementation of care bundles for treatment of postpartum hemorrhageMaría Fernanda Escobar, Paola Valencia, Lina María Jaimes, et al.
JTO Clinical and Research Reports|September 6, 2022
First-Line Pembrolizumab Monotherapy for Advanced NSCLC With Programmed Death-Ligand 1 Expression Greater Than or Equal to 50%: Real-World Study Including Older Patients in JapanYasushi Goto, Atsuhisa Tamura, Hirotaka Matsumoto, et al.
PLOS Global Public Health|November 1, 2024
"How I wish we could manage such things": A qualitative assessment of barriers to postpartum hemorrhage management and referral in KenyaNora Miller, Junita Henry, Kennedy Opondo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 2, 2009
Human biospecimen research: experimental protocol and quality control toolsFotini Betsou, Rebecca Barnes, Thomas Burke, et al.
Cancers|June 24, 2022
Real-World Treatments and Clinical Outcomes in Advanced NSCLC without Actionable Mutations after Introduction of Immunotherapy in JapanHiroshi Nokihara, Takashi Kijima, Toshihide Yokoyama, et al.
The Journal of Infectious Diseases|January 21, 2016
Transcriptomic Analysis of the Host Response and Innate Resilience to Enterotoxigenic Escherichia coli Infection in HumansWilliam E Yang, Sunil Suchindran, Bradly P Nicholson, et al.
Pageof 11